These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35279244)

  • 21. An antibacterial hydroxy fusidic acid analogue from Acremonium crotocinigenum.
    Evans L; Hedger JN; Brayford D; Stavri M; Smith E; O'Donnell G; Gray AI; Griffith GW; Gibbons S
    Phytochemistry; 2006 Oct; 67(19):2110-4. PubMed ID: 16930645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renaissance of vancomycin: approaches for breaking antibiotic resistance in multidrug-resistant bacteria.
    Mühlberg E; Umstätter F; Kleist C; Domhan C; Mier W; Uhl P
    Can J Microbiol; 2020 Jan; 66(1):11-16. PubMed ID: 31545906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fusidic and helvolic acid inhibition of elongation factor 2 from the archaeon Sulfolobus solfataricus.
    De Vendittis E; De Paola B; Gogliettino MA; Adinolfi BS; Fiengo A; Duvold T; Bocchini V
    Biochemistry; 2002 Dec; 41(50):14879-84. PubMed ID: 12475236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Construction of a new class of tetracycline lead structures with potent antibacterial activity through biosynthetic engineering.
    Lešnik U; Lukežič T; Podgoršek A; Horvat J; Polak T; Šala M; Jenko B; Harmrolfs K; Ocampo-Sosa A; Martínez-Martínez L; Herron PR; Fujs Š; Kosec G; Hunter IS; Müller R; Petković H
    Angew Chem Int Ed Engl; 2015 Mar; 54(13):3937-40. PubMed ID: 25650563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fusidic Acid: A Bacterial Elongation Factor Inhibitor for the Oral Treatment of Acute and Chronic Staphylococcal Infections.
    Fernandes P
    Cold Spring Harb Perspect Med; 2016 Jan; 6(1):a025437. PubMed ID: 26729758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unconventional Antibacterials and Adjuvants.
    Chang M; Mahasenan KV; Hermoso JA; Mobashery S
    Acc Chem Res; 2021 Feb; 54(4):917-929. PubMed ID: 33512995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multidrug-resistant gram-negative organisms: a review of recently approved antibiotics and novel pipeline agents.
    Provenzani A; Hospodar AR; Meyer AL; Leonardi Vinci D; Hwang EY; Butrus CM; Polidori P
    Int J Clin Pharm; 2020 Aug; 42(4):1016-1025. PubMed ID: 32638294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Curative Treatment of Severe Gram-Negative Bacterial Infections by a New Class of Antibiotics Targeting LpxC.
    Lemaître N; Liang X; Najeeb J; Lee CJ; Titecat M; Leteurtre E; Simonet M; Toone EJ; Zhou P; Sebbane F
    mBio; 2017 Jul; 8(4):. PubMed ID: 28743813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent developments in tetracycline antibiotics.
    Sum PE; Sum FW; Projan SJ
    Curr Pharm Des; 1998 Apr; 4(2):119-32. PubMed ID: 10197036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacology of polymyxins: new insights into an 'old' class of antibiotics.
    Velkov T; Roberts KD; Nation RL; Thompson PE; Li J
    Future Microbiol; 2013 Jun; 8(6):711-24. PubMed ID: 23701329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bacterial outer membrane vesicles as potential biological nanomaterials for antibacterial therapy.
    Huang W; Meng L; Chen Y; Dong Z; Peng Q
    Acta Biomater; 2022 Mar; 140():102-115. PubMed ID: 34896632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploiting genomics, genetics and chemistry to combat antibiotic resistance.
    Hughes D
    Nat Rev Genet; 2003 Jun; 4(6):432-41. PubMed ID: 12776213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toward computer-made artificial antibiotics.
    Torres MT; de la Fuente-Nunez C
    Curr Opin Microbiol; 2019 Oct; 51():30-38. PubMed ID: 31082661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The ADEP Biosynthetic Gene Cluster in Streptomyces hawaiiensis NRRL 15010 Reveals an Accessory
    Thomy D; Culp E; Adamek M; Cheng EY; Ziemert N; Wright GD; Sass P; Brötz-Oesterhelt H
    Appl Environ Microbiol; 2019 Oct; 85(20):. PubMed ID: 31399403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemistry and biology of the ramoplanin family of peptide antibiotics.
    McCafferty DG; Cudic P; Frankel BA; Barkallah S; Kruger RG; Li W
    Biopolymers; 2002; 66(4):261-84. PubMed ID: 12491539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonribosomal antibacterial peptides that target multidrug-resistant bacteria.
    Liu Y; Ding S; Shen J; Zhu K
    Nat Prod Rep; 2019 Apr; 36(4):573-592. PubMed ID: 30324212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How To Make a Glycopeptide: A Synthetic Biology Approach To Expand Antibiotic Chemical Diversity.
    Yim G; Wang W; Thaker MN; Tan S; Wright GD
    ACS Infect Dis; 2016 Sep; 2(9):642-650. PubMed ID: 27759388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibacterial Compounds from Marine Bacteria, 2010-2015.
    Schinke C; Martins T; Queiroz SCN; Melo IS; Reyes FGR
    J Nat Prod; 2017 Apr; 80(4):1215-1228. PubMed ID: 28362500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potent Antibiotics Active against Multidrug-Resistant Gram-Negative Bacteria.
    Otsuka Y
    Chem Pharm Bull (Tokyo); 2020; 68(3):182-190. PubMed ID: 32115524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chalcone derivatives and their antibacterial activities: Current development.
    Xu M; Wu P; Shen F; Ji J; Rakesh KP
    Bioorg Chem; 2019 Oct; 91():103133. PubMed ID: 31374524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.